Piramal Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,139.87 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.70 per cent from ₹2,043.72 crore. This corresponds to a year-on-year *(YoY) decline of 2.92 per cent.
Operating Profit
Operating Profit stands at ₹142.74 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.33 per cent from ₹162.81 crore. This corresponds to a year-on-year *(YoY) growth of 7.74 per cent.
PBDT
PBDT stands at ₹255.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.32 per cent from ₹255.88 crore. This corresponds to a year-on-year *(YoY) decline of 1.87 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-93.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 103.25 per cent from ₹-46.18 crore. This corresponds to a year-on-year *(YoY) decline of 240.51 per cent.
Net Profit
Net Profit stands at ₹-95.08 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.17 per cent from ₹-99.22 crore. This represents a 2,683.70 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Piramal Pharma Ltd News
Piramal Pharma Ltd Earnings
- YOY
- QOQ
Piramal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Piramal Pharma Ltd Research Reports
Piramal Pharma Ltd Financial Reports
Piramal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Piramal Pharma | -0.68% | 0.62% | -10.82% | -23.08% | -22.04% | -34.03% |
| Wockhardt | 1.05% | 1.62% | -5.25% | 6.92% | -17.81% | -3.22% |
| Pfizer | -2.95% | -0.13% | -7.68% | -11.67% | -11.59% | 1.41% |
| Astrazeneca Phar | -1.11% | 0.13% | -7.30% | -12.41% | -9.04% | 15.56% |
| ERIS Lifescience | -1.30% | 0.13% | -10.57% | -15.36% | -25.37% | 9.48% |
| Sai Life | -2.62% | 0.96% | -8.71% | -9.82% | 2.35% | 26.19% |
| Neuland Labs. | -2.20% | -1.95% | -17.39% | -24.02% | -5.44% | -11.22% |
Company Info
Company Information
Chairperson : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : S Rama Dorai
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Non-Exec & Non-Independent Dir : Nathalie Leitch
Independent Non Exe. Director : Vibha Paul Rishi
Company Sec. & Compli. Officer : Tanya Sanish